Page last updated: 2024-11-03

quipazine and Neuroblastoma

quipazine has been researched along with Neuroblastoma in 7 studies

Quipazine: A pharmacologic congener of serotonin that contracts smooth muscle and has actions similar to those of tricyclic antidepressants. It has been proposed as an oxytocic.

Neuroblastoma: A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51)

Research Excerpts

ExcerptRelevanceReference
"The pharmacological characteristics of 5-HT3 receptor (5-hydroxytryptamine3 receptor) recognition sites labelled with [3H]-(S)-zacopride and [3H]granisetron in membranes prepared from NG108-15 neuroblastoma-glioma cells were directly compared to investigate further differences in the binding characteristics of these two radioligands."7.68Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by [3H]-(S)-zacopride and [3H]granisetron. ( Barnes, JM; Barnes, NM, 1993)
" The biochemical and pharmacological properties of 5-HT3 receptors in homogenates of NG108-15 and NCB-20 neuroblastoma cells and rat cerebral cortex have been ascertained by the use of [3H]-quipazine and [3H]-GR65630 binding."7.68Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding. ( Eglen, RM; Loury, DN; Michel, AD; Sharif, NA; Stefanich, E; Whiting, RL; Wong, EH, 1991)
"The pharmacological characteristics of 5-HT3 receptor (5-hydroxytryptamine3 receptor) recognition sites labelled with [3H]-(S)-zacopride and [3H]granisetron in membranes prepared from NG108-15 neuroblastoma-glioma cells were directly compared to investigate further differences in the binding characteristics of these two radioligands."3.68Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by [3H]-(S)-zacopride and [3H]granisetron. ( Barnes, JM; Barnes, NM, 1993)
" The biochemical and pharmacological properties of 5-HT3 receptors in homogenates of NG108-15 and NCB-20 neuroblastoma cells and rat cerebral cortex have been ascertained by the use of [3H]-quipazine and [3H]-GR65630 binding."3.68Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding. ( Eglen, RM; Loury, DN; Michel, AD; Sharif, NA; Stefanich, E; Whiting, RL; Wong, EH, 1991)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rosen, T1
Seeger, TF1
McLean, S1
Nagel, AA1
Ives, JL1
Guarino, KJ1
Bryce, D1
Furman, J1
Roth, RW1
Chalabi, PM1
Cappelli, A1
Anzini, M1
Vomero, S1
Mennuni, L1
Makovec, F1
Doucet, E1
Hamon, M1
Bruni, G1
Romeo, MR1
Menziani, MC1
De Benedetti, PG1
Langer, T1
Wong, EH2
Bonhaus, DW1
Lee, JA1
Wu, I1
Loury, DN2
Eglen, RM2
Morain, P1
Abraham, C1
Lacoste, JM1
Malen, C1
Laubie, M1
Giesen-Crouse, E1
Barnes, JM1
Barnes, NM1
Newton, RA1
Phipps, SL1
Flanigan, TP1
Newberry, NR1
Carey, JE1
Kumar, C1
McDonald, B1
Chen, C1
Elliott, JM1
Sharif, NA1
Stefanich, E1
Michel, AD1
Whiting, RL1

Other Studies

7 other studies available for quipazine and Neuroblastoma

ArticleYear
Synthesis, in vitro binding profile, and central nervous system penetrability of the highly potent 5-HT3 receptor antagonist [3H]-4-(2-methoxyphenyl)-2-[4(5)-methyl-5(4)-imidazolylmethyl]thiazole.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:11

    Topics: Animals; Blood-Brain Barrier; Brain; Chemical Phenomena; Chemistry; Glioma; Imidazoles; Mice; Molecu

1990
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives.
    Journal of medicinal chemistry, 1998, Feb-26, Volume: 41, Issue:5

    Topics: Animals; Benzene; Binding Sites; Glioma; Guanidine; Mice; Models, Molecular; Molecular Structure; Ne

1998
Different densities of 5-HT3 receptors are labeled by [3H]quipazine, [3H]GR 65630 and [3H]granisetron.
    Neuropharmacology, 1993, Volume: 32, Issue:9

    Topics: Animals; Binding, Competitive; Cerebral Cortex; Cricetinae; Granisetron; Guinea Pigs; Ileum; Imidazo

1993
The antagonist properties of S 11978 on 5HT3 receptors in N1E-115 neuroblastoma cells.
    Fundamental & clinical pharmacology, 1993, Volume: 7, Issue:5

    Topics: Animals; Binding, Competitive; Electrophysiology; Indoles; Kinetics; Mice; Neuroblastoma; Ondansetro

1993
Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by [3H]-(S)-zacopride and [3H]granisetron.
    Biochemical pharmacology, 1993, May-25, Volume: 45, Issue:10

    Topics: Animals; Benzamides; Biguanides; Binding Sites; Binding, Competitive; Bridged Bicyclo Compounds; Bri

1993
Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs.
    Journal of neurochemistry, 1996, Volume: 67, Issue:6

    Topics: Adrenergic alpha-Agonists; Amphetamines; Antiparkinson Agents; Calcium; Choroid Plexus; Electrophysi

1996
Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
    British journal of pharmacology, 1991, Volume: 102, Issue:4

    Topics: Animals; Binding, Competitive; Cell Line; Cerebral Cortex; Imidazoles; Indoles; Kinetics; Ligands; M

1991